Baudax Bio, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • R&D
    • Product Portfolio
    • ANJESO® (meloxicam) injection
    • NMB & Reversal Agent
    • Investigator Sponsored Research
  • Therapeutic Areas
    • Post-Operative Pain
    • Anesthesia
  • News & Investors
    • Overview
    • Press Releases
    • Events
    • Presentations
    • Governance
    • Stock Info
    • Financial & Filings
  • Contact
  • Careers

Press Releases

News & Investors

News & Investors

  • Overview
  • Press Releases
  • Events
  • Presentations
  • Governance
    • Governance Documents
    • Board of Directors
    • Board Committees
  • Stock Info
    • Form 8937
  • Financial & Filings
    • Overview
    • All SEC Filings

Baudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business Update

Feb 23, 2023 8:00am EST

Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000

Jan 24, 2023 8:00am EST

Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery

Dec 08, 2022 8:00am EST

Baudax Bio Announces Closing of $5 Million Public Offering

Dec 06, 2022 4:11pm EST

Baudax Bio Announces Pricing of $5 Million Public Offering

Dec 02, 2022 2:46pm EST

Baudax Bio Announces 1-for-40 Reverse Stock Split

Nov 30, 2022 4:50pm EST

Baudax Bio Reports Third Quarter 2022 Financial Results and Business Highlights

Nov 08, 2022 4:09pm EST

Baudax Bio Announces Distribution of Series B Preferred Stock to Holders of its Common Stock

Sep 19, 2022 4:05pm EDT

Baudax Bio to Present at the 24th Annual H.C. Wainwright Healthcare Conference

Sep 08, 2022 4:05pm EDT

Baudax Bio Announces Closing of $6.2 Million Public Offering

Sep 01, 2022 2:56pm EDT
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...11
Next
  • Email Alerts
  • Tear Sheet
  • RSS News Feed
© 2023 Baudax Bio, Inc. All Rights Reserved. ANJESO is a registered trademark of Baudax Bio, Inc.
Privacy Policy Terms of Use Disclaimer Sitemap